CDEK
← All drugs Report issue

lobaplatin

Small moleculeexperimental

Clinical trial activity

29 trials · 22 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
24
Phase 3
10
Phase 4
3

Earliest trial started Dec 1, 2009 (NCT01034683)

Timeline

2000s

  1. Jan 1, 2009

    Earliest Phase 3 Sponsor(trial)

2010s

  1. Jan 1, 2011

    Earliest Phase 2 Sponsor(trial)

  2. Jan 1, 2016

    Earliest Phase 1 Sponsor(trial)

Indications

Approved for

Studied for

Mechanism of action

  • DNACROSS-LINKING AGENT

    DNA cross-linking agent

Chemistry & pharmacology

Mol. weight
397.33 g/mol
Chirality
Achiral Molecule
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • 1,2-diaminomethylcyclobutane-platinum(ii) lactate
  • d 19466
  • d-19466
  • lobalplatin
  • lobaplatin
  • lobaplatin
  • lobaplatin
  • lobaplatin

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT07093931Phase 4Aug 1, 2025Chinese Academy of Medical Sciences, Shandong University
NCT06714383Phase 2Nov 13, 2024Peking University
NCT06688175Phase 2Nov 13, 2024Xiamen University
NCT06198465Phase 2Mar 30, 2024Xijing Hospital
NCT06169410Phase 4Dec 30, 2023Xijing Hospital
NCT06586242Phase 2Apr 3, 2023Xijing Hospital
NCT05780294Phase 3Apr 1, 2023Sun Yat-Sen University
NCT06170697Phase 2Mar 1, 2023Chinese Academy of Medical Sciences
NCT05766605Phase 3Jan 1, 2023Southern Medical University
NCT05701436Phase 3Sep 1, 2022Southern Medical University
NCT04808466Phase 2Sep 18, 2021Huazhong University of Science and Technology
NCT04845490Phase 2Sep 1, 2021Huazhong University of Science and Technology
NCT05546255Phase 2Jun 1, 2020Chinese Academy of Medical Sciences
NCT03791918Phase 3Jan 1, 2019Guangzhou Medical University, Kaiping Central Hospital, Sun Yat-Sen University
NCT03700359Phase 2Nov 30, 2018Guangzhou Medical University
NCT03613753Phase 2Jun 1, 2018Guizhou Medical University
NCT03613597Phase 2Jun 1, 2018Guizhou Medical University
NCT03413436Phase 4Jan 31, 2018Henan Medical University, Zhengzhou University
NCT03308552Phase 3Sep 1, 2017Anyang Regional Hospital, Chinese Academy of Medical Sciences, Fujian Medical University, Hebei University, Nanjing Medical University, Tianjin Medical University, University of Electronic Science and Technology of China
NCT03328234Phase 3Sep 1, 2017Chinese Academy of Medical Sciences
Showing 20 of 29 trials
Page 1 / 2

Organizations

Research & Development (22)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Sun Yat-Sen UniversityAcademic/Hospital7732014
Chinese Academy of Medical SciencesAcademic/Hospital5432017
Guizhou Medical UniversityAcademic/Hospital3312016
Xijing HospitalAcademic/Hospital3322023
Guangzhou Medical UniversityAcademic/Hospital2122018
Huazhong University of Science and TechnologyAcademic/Hospital2212021
Kaiping Central HospitalAcademic/Hospital2012016
Southern Medical UniversityAcademic/Hospital2212022
Anyang Regional HospitalAcademic/Hospital1012017
China Association of Osteosarcoma ChemotherapyAcademic/Hospital1112014
Fujian Medical UniversityAcademic/Hospital1012017
Harbin Medical UniversityAcademic/Hospital1112011
Hebei UniversityAcademic/Hospital1012017
Henan Medical UniversityAcademic/Hospital1112018
Nanjing Medical UniversityAcademic/Hospital1012017
Peking UniversityAcademic/Hospital1112024
Shandong UniversityAcademic/Hospital1112025
Taian Cancer HospitalAcademic/Hospital1112009
Tianjin Medical UniversityAcademic/Hospital1012017
University of Electronic Science and Technology of ChinaAcademic/Hospital1012017
22 organizations
Page 1 / 2